NCT02484872View on ClinicalTrials.gov

Has Inflammation a Significant Implication in Lung Cancer Evolution?

UnknownOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions

Lung Neoplasms

Trial Locations (1)

1000

Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels

Sponsors

Collaborators (1)

Jules Bordet Institute

All Listed Sponsors

collaborator

Jules Bordet Institute

OTHER

lead

European Lung Cancer Working Party

OTHER

NCT02484872 - Has Inflammation a Significant Implication in Lung Cancer Evolution? | Biotech Hunter | Biotech Hunter